While glutamine catabolism was increased in CML CD34+ cells compared to normal CD34+ cells, the difference was not as pronounced as for glucose (lower fold changes; Fig. 1h and Supplementary Fig. S1F). The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.